Shares of Dr Reddys Laboratories experienced a decline of 0.67% to Rs 1228.00 during today's trading session, accompanied by ...

Dr. Reddy's Laboratories Ltd. closed 13.05% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr. Reddy's Laboratories Ltd. closed 14.11% below its 52-week high of 1,420.20 rupees, which the company achieved on August ...

Discover why Dr. Reddy’s Laboratories remains a strong buy amid robust revenue growth, underappreciated pipeline potential, ...

Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

Dr Reddys Laboratories shares experienced notable trading activity, with the price currently at Rs 1215.40, reflecting a 0.69 ...

Shares of Dr. Reddy’s Laboratories are on track to break through a critical range between ₹1,200 and ₹1,220 where surpassing ...

The sharp 250 basis points quarter-on-quarter decline in gross margin (the third consecutive sequential fall) reinforces ...

The pharma major reported revenue from operations of Rs 8,506 crore for the March quarter, marking a 20% increase compared to ...

Dr Reddy's Laboratories Ltd (NYSE:RDY) achieved record high revenue exceeding $3.8 billion and crossed the $1 billion threshold in EBITDA for the first time. The company reported a year-over-year ...

Dr. Reddy's Laboratories, a global pharmaceutical company, recently closed in early 2025 due to business and financial ...

The company reported a 22% year-on-year rise in consolidated net profit, reaching Rs 1,594 crore, surpassing analysts' ...